zavegepant intranasal (Pending FDA Approval)

Brand and Other Names:
  • Print
Sections

Dosing & Uses

Migraine

Pending FDA approval for treatment of acute migraine

Next:

Pharmacology

Mechanism of Action

Calcitonin gene-related peptide (CGRP) receptor antagonist; binds to CGRP receptor, which is thought to be causally involved in migraine pathophysiology

Previous
Next:

Images

No images available for this drug.
Previous
Next:

Patient Handout

A Patient Handout is not currently available for this monograph.
Previous
Medscape prescription drug monographs are based on FDA-approved labeling information, unless otherwise noted, combined with additional data derived from primary medical literature.